Douglas Doerfler - Nov 12, 2021 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
President and CEO, Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
MXCT
Transactions as of
Nov 12, 2021
Transactions value $
-$3,684,932
Form type
4
Date filed
11/16/2021, 06:08 PM
Previous filing
Aug 11, 2021
Next filing
Mar 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $73.90 +1.85K +0.43% $0.04* 435K Nov 12, 2021 Direct
transaction MXCT Common Stock Sale -$1.29M -102K -23.41% $12.66 333K Nov 12, 2021 Direct F1
transaction MXCT Common Stock Options Exercise $4.93K +123K +36.99% $0.04* 456K Nov 15, 2021 Direct
transaction MXCT Common Stock Sale -$1.5M -123K -27% $12.16 333K Nov 15, 2021 Direct F2
transaction MXCT Common Stock Options Exercise $3K +74.9K +22.48% $0.04* 408K Nov 16, 2021 Direct
transaction MXCT Common Stock Sale -$905K -74.9K -18.35% $12.08 333K Nov 16, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -1.85K -0.29% $0.00 643K Nov 12, 2021 Common Stock 1.85K $0.04 Direct F4
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -123K -19.16% $0.00 520K Nov 15, 2021 Common Stock 123K $0.04 Direct F4
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -74.9K -14.4% $0.00 445K Nov 16, 2021 Common Stock 74.9K $0.04 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 This option is fully vested and exercisable.